This miRNA has been reported as an oncomiR and biomarker in several types of cancer [122,123]; additionally, miR-224-5p binding to MAFF occurs in hepatocellular carcinoma [119]. The gene discussed is MAFF; the disease is hepatocellular carcinoma.